The tumor-associated antigen MUC1 is over-expressed by about three-fourths of all lethal human cancers, and was recently ranked number two by the NCI among all known tumor-associated antigens for meriting fast-tracked clinical prioritization [48]. The gene discussed is MUC1; the disease is cancer.